300 related articles for article (PubMed ID: 18978334)
21. Using genetic analysis to individualize preventive measures for breast and ovarian cancers.
Olopade OI
Nat Clin Pract Oncol; 2006 Apr; 3(4):182-3. PubMed ID: 16596140
[No Abstract] [Full Text] [Related]
22. Improving surveillance and quality of life of BRCA mutation carriers.
Loman N; Borg A
J Clin Oncol; 2010 Aug; 28(22):e376-7. PubMed ID: 20458044
[No Abstract] [Full Text] [Related]
23. Oral contraceptives, salpingo-oophorectomy and hormone replacement therapy in BRCA1-2 mutation carriers.
Biglia N; Mariani L; Ponzone R; Sismondi P
Maturitas; 2008 Jun; 60(2):71-7. PubMed ID: 18472232
[No Abstract] [Full Text] [Related]
24. Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families.
Hansen Tv; Jønson L; Albrechtsen A; Andersen MK; Ejlertsen B; Nielsen FC
Breast Cancer Res Treat; 2009 May; 115(2):315-23. PubMed ID: 18546071
[TBL] [Abstract][Full Text] [Related]
25. Receiving inconclusive genetic test results: an interpretive description of the BRCA1/2 experience.
Maheu C; Thorne S
Res Nurs Health; 2008 Dec; 31(6):553-62. PubMed ID: 18449940
[TBL] [Abstract][Full Text] [Related]
26. Communicating BRCA1 and BRCA2 genetic test results.
Gadzicki D; Wingen LU; Teige B; Horn D; Bosse K; Kreuz F; Goecke T; Schäfer D; Voigtländer T; Fischer B; Froster U; Welling B; Debatin I; Weber BH; Schönbuchner I; Nippert I; Schlegelberger B;
J Clin Oncol; 2006 Jun; 24(18):2969-70; author reply 2970-1. PubMed ID: 16782939
[No Abstract] [Full Text] [Related]
27. [In familial breast or ovarian carcinoma: normal cancer prevention is not enough].
Riem L
MMW Fortschr Med; 2004 Apr; 146(15):12. PubMed ID: 15373015
[No Abstract] [Full Text] [Related]
28. Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations.
Roukos DH
N Engl J Med; 2007 Oct; 357(15):1555-6; author reply 1556. PubMed ID: 17933033
[No Abstract] [Full Text] [Related]
29. Pretest genetic counseling informs patients with BRCA mutation.
Printz C
Cancer; 2012 Dec; 118(24):6017. PubMed ID: 23208671
[No Abstract] [Full Text] [Related]
30. Hereditary ovarian cancer--assessing risk and prevention strategies.
Pavelka JC; Li AJ; Karlan BY
Obstet Gynecol Clin North Am; 2007 Dec; 34(4):651-65, vii-viii. PubMed ID: 18061862
[TBL] [Abstract][Full Text] [Related]
31. Ratio of female to male offspring of women tested for BRCA1 and BRCA2 mutations.
Kotar K; Brunet JS; Møller P; Hugel L; Warner E; McLaughlin J; Wong N; Narod SA; Foulkes WD
J Med Genet; 2004 Aug; 41(8):e103. PubMed ID: 15286163
[No Abstract] [Full Text] [Related]
32. Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations.
Silva E; Lynch H
Breast J; 2006; 12(3):280-1; author reply 282-4. PubMed ID: 16684334
[No Abstract] [Full Text] [Related]
33. Can genetic testing guide treatment in breast cancer?
Tutt A; Ashworth A
Eur J Cancer; 2008 Dec; 44(18):2774-80. PubMed ID: 19027287
[TBL] [Abstract][Full Text] [Related]
34. High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.
Maehle L; Apold J; Paulsen T; Hagen B; Løvslett K; Fiane B; Van Ghelue M; Clark N; Møller P
Clin Cancer Res; 2008 Nov; 14(22):7569-73. PubMed ID: 19010876
[TBL] [Abstract][Full Text] [Related]
35. BRCA screening.
Obstet Gynecol; 2008 May; 111(5):1205-6. PubMed ID: 18448758
[No Abstract] [Full Text] [Related]
36. Strategies for ovarian cancer prevention.
Dann RB; Kelley JL; Zorn KK
Obstet Gynecol Clin North Am; 2007 Dec; 34(4):667-86, viii. PubMed ID: 18061863
[TBL] [Abstract][Full Text] [Related]
37. Advantages of the high resolution melting in the detection of BRCA1 or BRCA2 mutation carriers.
Jiménez Ide J; Esteban Cardeñosa E; Palanca Suela S; González EB; Bolufer Gilabert P;
Clin Biochem; 2009 Oct; 42(15):1572-6. PubMed ID: 19616529
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic mastectomy for BRCA1/2 carriers: progress and more questions.
Hartmann LC; Degnim A; Schaid DJ
J Clin Oncol; 2004 Mar; 22(6):981-3. PubMed ID: 14981099
[No Abstract] [Full Text] [Related]
39. Unraveling the next chapter: sexual development, body image, and sexual functioning in female BRCA carriers.
Matloff ET; Barnett RE; Bober SL
Cancer J; 2009; 15(1):15-8. PubMed ID: 19197168
[TBL] [Abstract][Full Text] [Related]
40. Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers.
Møller P; Hagen AI; Apold J; Maehle L; Clark N; Fiane B; Løvslett K; Hovig E; Vabø A
Eur J Cancer; 2007 Jul; 43(11):1713-7. PubMed ID: 17574839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
